Enhertu 100 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FMEB1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,384
Award facts
- Contract value 100% obligated
- $23,383.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $23,383.56 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 100 mg vials of Enhertu, a specialty oncology pharmaceutical. The delivery order, issued on December 8, 2025, with an ultimate completion date of December 9, 2025, was awarded without set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group serves as the prime contractor with no identified subcontractors on this award.
This delivery order was issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy established to support recurring medical supply needs of military healthcare facilities worldwide. The underlying PPV-G GEN V contract, designated SPE2DR, was awarded to DMS Pharmaceutical Group on November 13, 2025, with a $499,999,999 ceiling and extends through December 31, 2036. This structure enables the Defense Logistics Agency to issue multiple firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, positioning DMS Pharmaceutical Group as a critical pharmaceutical supplier for Department of Defense healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FMEB1?
SPE2DR26FMEB1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 8, 2025.
How much is contract SPE2DR26FMEB1 worth?
The government has obligated $23,384 on SPE2DR26FMEB1.
Is contract SPE2DR26FMEB1 an order under another contract?
Yes. SPE2DR26FMEB1 is a delivery order under SPE2DR25D9114, an indefinite delivery contract.
Was contract SPE2DR26FMEB1 competed?
The extent of competition for SPE2DR26FMEB1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award